Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Walgreens Boots Alliance Inc    

SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

Active Flu Season Boosts Walgreen's January Sales

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/05/2013 | 02:35pm CEST
   By John Kell 
 

Walgreen Co. (>> Walgreen Company) posted its first monthly same-store sales gain in a year in January, aided by an active flu season and firmer prescription orders stemming from the resolution of a contract dispute with a major pharmacy-benefits manager.

The 3.7% increase in same-store sales in January came above the projected 1.5% increase, according to analysts surveyed by Thomson Reuters.

Results last year were hurt by a rate contract dispute with pharmacy-benefits manager Express Scripts Holding Co. (>> Express Scripts Holding Co) that led millions to transfer their prescriptions to rival pharmacies. But since Walgreen and Express Scripts entered a new multiyear agreement that began in September, millions have returned to the fold.

The loss of the Express Scripts customers, as well as higher demand for lower-priced generic drugs, hurt Walgreen's same-store sales throughout 2012. In 2012, January's same-store sales dropped 4.6%.

Walgreen has also successfully courted some customers it had lost in the dispute and hopes to win back more, gains executives expect will be reflected in many of 2013's monthly sales reports. In January, pharmacy sales grew 8.7% and same-store pharmacy sales increased 6.2%, compared with an expected 2.4% jump. Prescriptions filled at comparable stores soared 14%.

Overall, total sales in January grew 6.3% to $6.15 billion from a year ago. Front-end sales were up 1.3%, while same-store front-end sales slid 0.4%, compared with expectations of a 0.5% drop.

Drugstore front-end sales have been helped by a nasty flu season, bolstering traffic and demand for prescriptions and over-the-counter treatments. Walgreen, which provides more flu vaccines in the U.S. than any other retailer, said it has administered 6.9 million flu vaccines so far this season, far above last year's 5.5 million.

But drugstore-retailer results have been stung by increasing demand for generic drugs, which Walgreen said hurt January's pharmacy same-store sales by six percentage points. Strong demand for those drugs products a mixed effect because copycat drugs carry higher margins than branded products but command lower prices, hurting same-store sales.

Last week, Rite Aid Corp. (>> Rite Aid Corporation) reported January same-store sales were up 0.3%, as a very active flu season helped offset the pressure from generics. CVS Caremark Corp. (>> CVS Caremark Corporation), which doesn't report monthly sales data, has already warned same-store sales in the first quarter would be lower. The company's full fourth-quarter results are due on Wednesday.

Walgreen's shares were inactive at $40.01 in premarket trading.

Write to John Kell at [email protected]

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on WALGREENS BOOTS ALLIANCE I
10:25a Fred's Pharmacy Appoints Two New Independent Directors; Announces Cooperation..
10:24a WALGREENS BOOTS ALLIANCE : and the American Society of Transplantation Collabora..
04/22 WALGREENS BOOTS ALLIANCE : pays $9.8 million settlement over drug billing
04/20 WALGREENS BOOTS ALLIANCE : Declares Regular Quarterly Dividend
04/19 WALGREENS BOOTS ALLIANCE, INC. : Change in Directors or Principal Officers, Othe..
04/19 WALGREENS BOOTS ALLIANCE : José E. Almeida, Chairman and CEO of Baxter Internati..
04/18 WALGREENS : Healthcare Clinics to Offer Testing Services for Sexually Transmitte..
04/18 WALGREENS BOOTS ALLIANCE : Inspires 'Noses On' Across America to Support Third A..
04/17 WALGREENS : Inspires “Noses On” Across America to Support Third Annu..
04/14 WALGREENS BOOTS ALLIANCE : Expands Beauty Offering with Addition of NYX Professi..
More news
Sector news : Drug Retailers - NEC
04/24DJEXPRESS SCRIPTS : Says It Will Lose Anthem, Its Biggest Customer, in 2020
04/19DJCardinal Swoops In, Strikes Deal -- WSJ
04/18DJCARDINAL HEALTH : $6.1 Billion Deal for Some Medtronic Operations Raises Debt Co..
04/18DJCARDINAL HEALTH : $6.1 Billion Deal for Some Medtronic Operations Raises Debt Co..
03/08DJHealth Costs Get a Rethink -- WSJ
More sector news : Drug Retailers - NEC
Advertisement
Financials ($)
Sales 2017 117 598 M
EBIT 2017 7 400 M
Net income 2017 4 539 M
Debt 2017 12 752 M
Yield 2017 1,80%
P/E ratio 2017 20,20
P/E ratio 2018 17,19
EV / Sales 2017 0,88x
EV / Sales 2018 0,81x
Capitalization 91 103 M
More Financials
Chart WALGREENS BOOTS ALLIANCE I
Duration : Period :
Walgreens Boots Alliance I Technical Analysis Chart | US9314221097 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
Consensus 
Mean consensus OUTPERFORM
Number of Analysts 25
Average target price 93,5 $
Spread / Average Target 11%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Stefano Pessina Executive Vice Chairman & Chief Executive Officer
James A. Skinner Executive Chairman
Ornella Barra Co-Chief Operating Officer
Alexander W. Gourlay Co-Chief Operating Officer
George Rollo Fairweather Global Chief Financial Officer & Executive VP
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
WALGREENS BOOTS ALLIAN..-0.07%91 103
WALGREENS BOOTS ALLIAN..1.84%91 103
CVS HEALTH CORP1.44%82 915
EXPRESS SCRIPTS HOLDIN..-2.24%40 371
MCKESSON CORPORATION-3.06%28 871
CARDINAL HEALTH INC0.71%22 864
More Results